VIE/RHK (VIE/RHK)

Vienna Stock Exchange: VIE/RHK · EUR

€14.4

+0.00 (0.0%)· Recorded snapshot

Market cap	957.2M
Revenue (ttm)	2B
Net income (ttm)	42.1M
EPS (ttm)	€0.63
P/E (trailing)	22.9x
P/E (forward)	22.4x
Dividend	€0.20 (1.39%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2B
Net income (ttm): 42.1M
EPS (ttm): €0.63
P/E (trailing): 22.9x
P/E (forward): 22.4x
Market cap: 957.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E22.4

P25 14.3P50 18.7P75 25.4

Trailing P/E22.9

P25 20.4P50 26.7P75 39.7

ROE3.3

P25 4.8P50 10.6P75 20.1

ROIC3.5

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/RHK indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

EUR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-05
Employees	19,120
Employees change	299
Employees growth	1.59%
Enterprise value	EUR 796.7M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1973
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	DE0007042301
Last earnings date	2026-08-06
Last refreshed	2026-10-30
Market cap	EUR 957.2M
Next earnings date	2026-11-05
Price	EUR 14.40
Price currency	EUR
Sector	Healthcare
SIC code	8060
Stock price date	2026-10-29
Symbol	vie/RHK
Website	https://www.rhoen-klinikum-ag.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	98.1x
Average P/E ratio (3Y)	20.54x
Average P/E ratio (5Y)	27.52x
Earnings yield	4.37%
EV/Earnings	18.93x
EV/EBIT	14.53x
EV/EBITDA	6.92x
EV/FCF	63.74x
EV/Sales	0.39x
FCF / EV yield	1.57%
FCF yield	1.31%
Forward P/E	22.42x
Graham number	17.07002
Graham upside	18.54%
Lynch fair value	EUR 15.83
Lynch upside	9.92%
P/B ratio	0.7x
P/E ratio	22.9x
P/FCF ratio	76.58x
P/OCF ratio	7.54x
P/S ratio	0.47x
Price / tangible book value	0.83x
Price/EBITDA ratio	8.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.7%
EBITDA margin	5.51%
Effective tax rate	19.73%
FCF margin	0.62%
Gross margin	10.74%
Operating margin	2.7%
Pretax margin	2.71%
Profit margin	2.08%
Profit per employee	EUR 2,201
Profitable quarters	22
Profitable years	24
Revenue per employee	EUR 106,038
ROA	1.85%
ROA (5Y)	1.35%
ROCE	3.7%
ROE	3.28%
ROE (5Y)	2.81%
ROIC	3.53%
ROIC (5Y)	2.91%
Tax / revenue	0.53%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	12.28%
EPS growth (Q)	40%
EPS growth (QoQ)	-26.32%
EPS growth 10Y	-8.59%
EPS growth 3Y	18%
EPS growth 5Y	25.74%
EPS growth quarters	2
EPS growth years	0
FCF growth 5Y	-11.48%
Gross profit growth	28.6%
Gross profit growth (Q)	18.85%
Gross profit growth 3Y	-2.32%
Gross profit growth 5Y	6.2%
Net income growth	11.69%
Net income growth (Q)	29.01%
Net income growth (QoQ)	-28.92%
Net income growth 3Y	18%
Net income growth 5Y	25.09%
Net income growth quarters	2
Net income growth years	0
OCF growth	105.84%
OCF growth 10Y	2.36%
OCF growth 3Y	43.14%
OCF growth 5Y	1.71%
Operating income growth	18.35%
Operating income growth (Q)	28.75%
Operating income growth 3Y	24.56%
Operating income growth 5Y	26.5%
Revenue growth	5.72%
Revenue growth (Q)	4.95%
Revenue growth (QoQ)	-0.67%
Revenue growth 10Y	4.74%
Revenue growth 3Y	6.17%
Revenue growth 5Y	5.47%
Revenue growth quarters	10
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -114.5M
Depreciation and amortization	EUR 56.9M
EBIT	EUR 54.8M
EBITDA	EUR 111.7M
EPS	EUR 0.63
Financing cash flow	EUR -49.3M
Free cash flow	EUR 12.5M
Gross profit	EUR 217.7M
Income taxes	EUR 10.8M
Investing cash flow	EUR -131.2M
Net borrowing	EUR -34.5M
Net cash flow	EUR -53.5M
Net income	EUR 42.1M
Operating income	EUR 54.8M
Revenue	EUR 2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.09
Book value per share	EUR 19.86
Debt / EBITDA	1.06
Debt / equity	0.09
Debt / FCF	9.75
Goodwill	EUR 167M
Interest coverage	18.55
Long-term assets	EUR 919.9M
Long-term liabilities	EUR 122.2M
Net cash (debt)	EUR 190.9M
Net cash / market cap	19.94%
Net cash growth	-1.61%
Net debt / EBITDA	-1.71
Net debt / equity	-0.14
Net debt / FCF	-15.27
Piotroski F-Score	7
Property, plant and equipment	EUR 733.5M
Shareholders' equity	EUR 1.4B
Tangible book value	EUR 1.2B
Tangible book value per share	EUR 17.24
Total assets	EUR 1.8B
Total cash	EUR 312.8M
Total debt	EUR 121.9M
Total liabilities	EUR 466.9M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.1
Current assets	EUR 906.7M
Current liabilities	EUR 344.7M
Current ratio	2.63
Inventory turnover	45.54
Net working capital	EUR 254.2M
Quick ratio	2.36
Working capital	EUR 562M
Working capital turnover	3.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	100%
Dividend growth (3Y)	10.06%
Dividend growth (5Y)	-7.16%
Dividend growth years	0
Dividend payment date	2026-06-01
Dividend payment years	2
Dividend per share	EUR 0.20
Dividend yield	1.39%
Ex-dividend date	2026-05-28
Last dividend	EUR 0.20
Payout ratio	31.84%
Shareholder yield	1.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 13.43
1D price change	0%
1W price change	-1.37%
1W total return	-1.37%
1Y price change	22.03%
1Y return CAGR	24.02%
1Y total return	24%
20-day SMA	EUR 14.48
200-day SMA	EUR 13.32
3M price change	13.39%
3M total return	13.39%
3Y price change	27.43%
3Y return CAGR	9.28%
3Y total return	30.52%
50-day SMA	EUR 14.50
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 15.20
52-week high date	2026-08-07
52-week low	EUR 11.30
52-week low date	2026-06-01
5Y price change	-8.28%
5Y return CAGR	-1.01%
5Y total return	-4.94%
6M price change	17.07%
6M total return	18.96%
All-time high	EUR 31.66
All-time high date	2018-01-31
All-time low	EUR 9.65
All-time low date	2024-02-07
Average true range (ATR)	EUR 0.15
Average volume	0
Change from 52-week high	-5.26%
Change from 52-week low	27.43%
Change from all-time high	-54.52%
Change from all-time low	49.22%
Change from open	-0.69%
Day's gap	0.69%
High price	EUR 14.50
Low price	EUR 14.30
Monthly RSI	58.82
Open price	EUR 14.50
Position in 52-week range	50%
Previous close	EUR 14.40
Price vs 150-day SMA	7.22%
Price vs 20-day SMA	-0.55%
Price vs 200-day SMA	8.11%
Price vs 50-day SMA	-0.72%
Relative volume	6.09
RSI	44.9
Sharpe ratio	0.75
Sharpe ratio (3Y)	0.3
Sharpe ratio (5Y)	-0.05
Sortino ratio	1.69
Sortino ratio (3Y)	0.69
Sortino ratio (5Y)	0.15
Weekly RSI	58.62
YTD price change	11.63%
YTD total return	13.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.7M
Shares change (QoQ)	-3.53%
Shares held by institutions	0.53%

Deeper analysis on VIE/RHK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/RHK report

Is a complete VIE/RHK research report available?

No complete published report is available for vie/RHK (VIE/RHK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/RHK (VIE/RHK)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/RHK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/RHK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/RHK

Frequently asked questions